For 66-year-old Tim Andrews, it was a matter of life or death. Andrews had spent the better part of two years on dialysis because of end-stage kidney disease. He was on the transplant wait list for a ...
A year after guidelines were revised to remove the use of race in eGFR, many labs and pathologists were still relying on the ...
The U.S. Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only ...
The FDA will allow two biotechnology companies to run clinical trials: United Therapeutics and eGenesis. United Therapeutics ...
GLP-1 medications are renowned for their ability to treat type 2 diabetes and aid weight loss. Now, there's a new benefit to ...
Ozempic has been approved to reduce the risk of worsening kidney disease and cardiovascular death in adults with Type 2 ...
Nephrologists jumped on the GLP-1 bandwagon well before Novo Nordisk won FDA approval for Ozempic in chronic kidney disease ...
The U.S. Food and Drug Administration has approved Genentech's Susvimo (ranibizumab) 100 mg/mL for treating diabetic macular ...
Dr. Tycel Phillips discusses the FDA approval of a Calquence combo in MCL, making it the first and only BTK inhibitor ...
The FDA has approved clinical trials for organ transplants using genetically modified pigs, starting with six patients with ...
The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.
The US Food and Drug Administration approved clinical trials that will transplant organs from genetically modified pigs into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback